This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Kelcy Newell - Innovator in Antibody Formulations
Introduction
Kelcy Newell is an inventor based in Gaithersburg, MD (US). He currently works at AstraZeneca AB, where he focuses on developing innovative solutions in the field of antibody formulations. Despite having no granted patents to his name, his contributions to the field are noteworthy.
Latest Patent Applications
Kelcy Newell's latest patent applications include "Stable, Aqueous Formulations of Antibodies that Bind IL5 Receptor." This invention relates to stable, aqueous antibody formulations. In some embodiments, the stable, aqueous formulations comprise about 2 mg/mL to about 100 mg/mL of an anti-IL5R antibody, and about 0.002% to about 0.01% polysorbate-20. The application also provides methods of making and using such antibody formulations.
Conclusion
Kelcy Newell is making significant strides in the development of stable antibody formulations, showcasing his innovative spirit and dedication to advancing medical science.